Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Maijiarui Biotechnology is a specialized medical technology company based in Shenzhen, China, focusing on the field of in vitro diagnostics (IVD). The company primarily develops and manufactures molecular diagnostic solutions, including fluorescence quantitative PCR kits and automated nucleic acid extraction systems. Their product portfolio is designed to address clinical needs in infectious disease detection, genetic screening, and personalized medicine. Maijiarui integrates research, production, and sales to provide comprehensive laboratory workflows for hospitals and diagnostic centers. The company is recognized as a National High-tech Enterprise and maintains rigorous quality standards through ISO 13485 certification. Their diagnostic assays target a wide range of pathogens, including respiratory and gastrointestinal viruses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Maijiarui Biotechnology.